Drug which may lead to hemolysis in a child with G6PD deficiency is
Common drugs associated with G6PD deficiency include sulfonamides, nitrofurantoin, and some antimalarials like primaquine. Also, certain antibiotics like tetracyclines and aspirin in high doses might be implicated. The key here is to remember the classic examples. For example, sulfamethoxazole is a sulfonamide that's often listed as a trigger. Primaquine is another one, especially used in malaria treatment. Nitrofurantoin, which is an antibiotic for UTIs, is also known to cause this.
Now, looking at the options, if any of these are present, that's the correct answer. Let's say the options are A: Penicillin, B: Sulfamethoxazole, C: Amoxicillin, D: Ciprofloxacin. Then B would be correct because sulfamethoxazole is a sulfonamide and a well-known culprit. The other options are not typically associated with G6PD deficiency. Penicillin and amoxicillin are beta-lactams, which are generally safe. Ciprofloxacin is a fluoroquinolone and not linked to this issue.
I should also make sure about the mechanism. G6PD deficiency leads to a lack of NADPH production, which is necessary for maintaining glutathione levels. Without enough reduced glutathione, the RBCs can't handle oxidative stress, leading to Heinz body formation and hemolysis. The drugs that cause this are usually those that generate reactive oxygen species or interfere with the antioxidant pathways in the RBCs.
So, in the explanation, I need to highlight the core concept of G6PD deficiency and oxidative stress. Then explain why the correct drug (like sulfamethoxazole) is the answer. For the incorrect options, mention why they don't trigger hemolysis in this condition. The clinical pearl would be to remember the mnemonic "SULF" for sulfonamides, or other acronyms that include the key drugs. Also, note that penicillins and cephalosporins are safe, which is a common exam trap.
**Core Concept**
G6PD deficiency is an X-linked recessive enzyme disorder that impairs the pentose phosphate pathway, reducing NADPH production. This leads to inadequate glutathione synthesis, making red blood cells vulnerable to oxidative stress-induced hemolysis when exposed to certain drugs.
**Why the Correct Answer is Right**
Sulfonamides (e.g., sulfamethoxazole) are oxidizing agents that generate reactive oxygen species, triggering Heinz body formation and acute hemolysis in G6PD-deficient individuals. The lack of NADPH prevents the regeneration of reduced glutathione, which is critical for scavenging these harmful byproducts. This mechanism directly links sulfonamides to hemolytic an